Anti-IL31RA(nemolizumab biosimilar) mAb

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
DIM-BME100231.50	50 µg		-	-	7 - 16 business days*		120.00€
DIM-BME100231.100	100 µg		-	-	7 - 16 business days*		237.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Protein function: Associates with OSMR to form the interleukin-31 receptor which activates STAT3... more

Close menu

Product information "Anti-IL31RA(nemolizumab biosimilar) mAb"

Protein function: Associates with OSMR to form the interleukin-31 receptor which activates STAT3 and to a lower extent STAT1 and STAT5 (PubMed:11877449, PubMed:14504285, PubMed:15627637, PubMed:15194700). May function in skin immunity (PubMed:15184896). Mediates IL31-induced itch, probably in a manner dependent on cation channels TRPA1 and TRPV1. Positively regulates numbers and cycling status of immature subsets of myeloid progenitor cells in bone marrow in vivo and enhances myeloid progenitor cell survival in vitro. [The UniProt Consortium]

Keywords:	Anti-CRL, Anti-GPL, Anti-CRL3, Anti-GLMR, Anti-GLM-R, Anti-PLCA2, Anti-hGLM-R, Anti-IL-31RA, Anti-PRO21384, Anti-zcytoR17, Anti-IL31RA(nemolizumab biosimilar) mAb
Supplier:	DIMA
Supplier-Nr:	BME100231